Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease

Experimental Eye Research

Volumn 127, Issue , 2014, Pages 252-260

  Edwards, Malia M ^a   Rodríguez, José J ^b,c   Gutierrez Lanza, Raquel ^b   Yates, Joseph ^a   Verkhratsky, Alexei ^b,c,d   Lutty, Gerard A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer's disease; Astrogliosis; GFAP; M ller cells; Retina

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GLUTAMATE AMMONIA LIGASE; PRESENILIN 1; TAU PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S 100;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; COGNITION; CONTROLLED STUDY; CRYOPRESERVATION; CYTOPLASM; IMMUNOHISTOCHEMISTRY; MACROGLIA; MOUSE; NERVE CELL; NONHUMAN; PRIMARY CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE; AMYLOID PLAQUE; ANIMAL TISSUE; CELL ACTIVATION; CELL COUNT; CELL LABELING; CELLULAR DISTRIBUTION; DIFFUSION; GENE; HUMAN; NEUROFIBRILLARY TANGLE; PROTEIN EXPRESSION; PROTEIN SECRETION; RETINA;

ALZHEIMER'S DISEASE; ASTROGLIOSIS; GFAP; MÜLLER CELLS; RETINA;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; CELL COUNT; DISEASE MODELS, ANIMAL; EPENDYMOGLIAL CELLS; GLIOSIS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PRESENILIN-1; RETINAL NEURONS; S100 PROTEINS; TAU PROTEINS;

EID: 84907316362     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.08.006     Document Type: Article

References (47)

1. Beach T.G., McGeer E.G. Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex. Brain Res. 1988, 463:357-361.
2. Bittner T., Fuhrmann M., Burgold S., Ochs S.M., Hoffmann N., Mitteregger G., Kretzschmar H., LaFerla F.M., Herms J. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS One 2010, 5:e15477.
3. Blanks J.C., Hinton D.R., Sadun A.A., Miller C.A. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res. 1989, 501:364-372.
4. Blanks J.C., Schmidt S.Y., Torigoe Y., Porrello K.V., Hinton D.R., Blanks R.H. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol. Aging 1996, 17:385-395.
5. Blanks J.C., Torigoe Y., Hinton D.R., Blanks R.H. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol. Aging 1996, 17:377-384.
6. Edwards M.M., McLeod D.S., Grebe R., Heng C., Lefebvre O., Lutty G.A. Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice. BMC Dev. Biol. 2011, 11:60.
7. Eisenfeld A.J., Bunt-Milam A.H., Sarthy P.V. Muller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Investig. Ophthalmol. Vis. Sci. 1984, 25:1321-1328.
8. Fischer F., Martin G., Agostini H.T. Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy. J.Neuroinflammation 2011, 8:120.
9. Fisher S.K., Lewis G.P. Muller cell and neuronal remodeling in retinal detachment and reattachment and their potential consequences for visual recovery: a review and reconsideration of recent data. Vis. Res. 2003, 43:887-897.
10. Hedges T.R., Perez Galves R., Speigelman D., Barbas N.R., Peli E., Yardley C.J. Retinal nerve fiber layer abnormalities in Alzheimer's disease. Acta Ophthalmol. Scand. 1996, 74:271-275.
11. Heneka M.T., Rodriguez J.J., Verkhratsky A. Neuroglia in neurodegeneration. Brain Res. Rev. 2010, 63:189-211.
12. Hinton D.R., Sadun A.A., Blanks J.C., Miller C.A. Optic-nerve degeneration in Alzheimer's disease. N.Engl. J. Med. 1986, 315:485-487.
13. Hirrlinger P.G., Ulbricht E., Iandiev I., Reichenbach A., Pannicke T. Alterations in protein expression and membrane properties during Muller cell gliosis in a murine model of transient retinal ischemia. Neurosci. Lett. 2010, 472:73-78.
14. Ho C.Y., Troncoso J.C., Knox D., Stark W., Eberhart C.G. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients. Brain Pathol. 2013 Jan, 24(1):25-32.
15. Huang H., Parlier R., Shen J.K., Lutty G.A., Vinores S.A. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. PLoS One 2013, 8:e71808.
16. Koronyo-Hamaoui M., Koronyo Y., Ljubimov A.V., Miller C.A., Ko M.K., Black K.L., Schwartz M., Farkas D.L. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive invivo optical imaging of retinal plaques in a mouse model. Neuroimage 2011, 54(Suppl.1):S204-S217.
17. Kulijewicz-Nawrot M., Verkhratsky A., Chvatal A., Sykova E., Rodriguez J.J. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J.Anat. 2012, 221:252-262.
18. Liu B., Rasool S., Yang Z., Glabe C.G., Schreiber S.S., Ge J., Tan Z. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer's transgenic mice. Am. J. Pathol. 2009, 175:2099-2110.
19. Marshak D.R., Pesce S.A., Stanley L.C., Griffin W.S. Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging 1992, 13:1-7.
20. Mrak R.E., Sheng J.G., Griffin W.S. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J.Neuropathol. Exp. Neurol. 1996, 55:273-279.
21. Ning A., Cui J., To E., Ashe K.H., Matsubara J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Investig. Ophthalmol. Vis. Sci. 2008, 49:5136-5143.
22. Oddo S., Caccamo A., Kitazawa M., Tseng B.P., LaFerla F.M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging 2003, 24:1063-1070.
23. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
24. Olabarria M., Noristani H.N., Verkhratsky A., Rodriguez J.J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 2010, 58:831-838.
25. Olabarria M., Noristani H.N., Verkhratsky A., Rodriguez J.J. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?. Mol. Neurodegener. 2011, 6:55.
26. Perez S.E., Lumayag S., Kovacs B., Mufson E.J., Xu S. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. Investig. Ophthalmol. Vis. Sci. 2009, 50:793-800.
27. Robinson S.R. Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease. J.Neurosci. Res. 2001, 66:972-980.
28. Rodriguez J.J., Jones V.C., Tabuchi M., Allan S.M., Knight E.M., LaFerla F.M., Oddo S., Verkhratsky A. Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease. PLoS One 2008, 3:e2935.
29. Rodriguez J.J., Noristani H.N., Hilditch T., Olabarria M., Yeh C.Y., Witton J., Verkhratsky A. Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease. Neurosci. Lett. 2013, 552:129-134.
30. Rodriguez J.J., Olabarria M., Chvatal A., Verkhratsky A. Astroglia in dementia and Alzheimer's disease. Cell Death Differ. 2009, 16:378-385.
31. Rodriguez J.J., Verkhratsky A. Neuroglial roots of neurodegenerative diseases?. Mol. Neurobiol. 2011, 43:87-96.
32. Rodriguez M.J., Prats A., Malpesa Y., Andres N., Pugliese M., Batlle M., Mahy N. Pattern of injury with a graded excitotoxic insult and ensuing chronic medial septal damage in the rat brain. J.Neurotrauma 2009, 26:1823-1834.
33. Sarthy P.V., Fu M., Huang J. Developmental expression of the glial fibrillary acidic protein (GFAP) gene in the mouse retina. Cell. Mol. Neurobiol. 1991, 11:623-637.
34. Sarthy V., Egal H. Transient induction of the glial intermediate filamentprotein gene in Muller cells in the mouse retina. DNA Cell Biol. 1995, 14:313-320.
35. Schipper H.M., Bennett D.A., Liberman A., Bienias J.L., Schneider J.A., Kelly J., Arvanitakis Z. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol. Aging 2006, 27:252-261.
36. Sheng J.G., Mrak R.E., Bales K.R., Cordell B., Paul S.M., Jones R.A., Woodward S., Zhou X.Q., McGinness J.M., Griffin W.S. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J.Neurochem. 2000, 74:295-301.
37. Sheng J.G., Mrak R.E., Griffin W.S. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J.Neurosci. Res. 1994, 39:398-404.
38. Sheng J.G., Mrak R.E., Rovnaghi C.R., Kozlowska E., Van Eldik L.J., Griffin W.S. Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol. Aging 1996, 17:359-363.
39. Shimazawa M., Inokuchi Y., Okuno T., Nakajima Y., Sakaguchi G., Kato A., Oku H., Sugiyama T., Kudo T., Ikeda T., Takeda M., Hara H. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. J.Neurochem. 2008, 107:279-290.
40. Steele M.L., Robinson S.R. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol. Aging 2012, 33(423). e421-413.
41. Tsai Y., Lu B., Ljubimov A.V., Girman S., Ross-Cisneros F.N., Sadun A., Svendsen C.N., Cohen R.M., Wang S. Ocular changes in TgF344-AD ratmodel of Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 2014, 55:523-534.
42. Van Eldik L.J., Griffin W.S. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta 1994, 1223:398-403.
43. Van Eldik L.J., Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor. Neurol. Neurosci. 2003, 21:97-108.
44. Verkhratsky A., Olabarria M., Noristani H.N., Yeh C.Y., Rodriguez J.J. Astrocytes in Alzheimer's disease. Neurotherapeutics 2010, 7:399-412.
45. Verkhratsky A., Sofroniew M.V., Messing A., deLanerolle N.C., Rempe D., Rodriguez J.J., Nedergaard M. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 2012, 4.
46. Wharton S.B., O'Callaghan J.P., Savva G.M., Nicoll J.A., Matthews F., Simpson J.E., Forster G., Shaw P.J., Brayne C., Ince P.G. Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia. Dement. Geriatr. Cogn. Disord. 2009, 27:465-473.
47. Yeh C.Y., Vadhwana B., Verkhratsky A., Rodriguez J.J. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neuro 2011, 3:271-279.